FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

17,881 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 11200 - 11400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
signal.core.r4R4questionnaire-ccars-history-of-mental-health-servicesQuestionnaire CCARS History Of Mental Health Servicesdraft1paus
hl7.fhir.us.dme-ordersR4PAOx-Message-EventPAO Message Eventdraft2023-06usfhir
us.nlm.vsacR42.16.840.1.113762.1.4.1235.15MetabolicSyndromeConditionactive2025-01usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.9Metabolic Syndrome ICD10active2025-03usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1235.12Metabolic Syndrome LOINCactive2025-02usloinc
hl7.fhir.uv.bulkdataR4include-associated-dataInclude Associated Data Value Settrial-use5fhir2021-07uvfhir
us.nlm.vsacR42.16.840.1.113762.1.4.1260.33Metastatic Breast Canceractive2023-09ussct
hl7.fhir.us.codex-radiation-therapyR4codexrt-radiotherapy-respiratory-motion-management-vsRadiotherapy Respiratory Motion Management Value Setactivecgp2025-02ussct
hl7.terminologyR5attribute-estimate-typeStatisticAttributeEstimateTypeactive5fhir2024-04uvtho
hl7.cda.us.eyecareR5RefractionMethodCodesRefraction Method Codesdraft2024-02ussct
hl7.cda.us.eyecareR5VisualAcuityMethodCodesVisual Acuity Method Codesdraft2024-02ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1260.49MSI Testingactive2023-11usloinc
hl7.fhir.us.military-serviceR4military-service-branch-vsMilitary Branch Value Setactive2023-05usfhir
hl7.fhir.us.military-serviceR4military-service-military-occupation-vsMilitary Occupation Value Setactive2023-05usfhir
hl7.fhir.us.directory-queryR4MinEndpointConnectionTypeVSMinimum Endpoint Connection Types Value Setactive2022-12usfhir tho
hl7.fhir.us.davinci-pdex-plan-netR4MinEndpointConnectionTypeVSMinimum Endpoint Connection Types VStrial-usefm2025-02usfhir tho
hl7.fhir.it.terminologyR4minsan-idAouMinistero della Salute - ID Aziende Ospedaliere Universitarieactive2025-06itinternal
hl7.fhir.it.terminologyR4minsan-idAziendeOspedaliereMinistero della Salute - ID Aziende Ospedaliereactive2025-06itinternal
hl7.fhir.it.terminologyR4minsan-regioneMinistero della Salute - Codici Regionaliactive2025-06itinternal
eng.fhir.profile.devR4929ee538-9d40-4409-87ea-97c3d787899fMinistero della Salute - Codici Regionaliactive2023-06
hl7.fhir.it.terminologyR4strutturePubblicheMinistero della Salute - Codici strutture di ricovero pubblicheactive2025-06itinternal
hl7.fhir.it.terminologyR4vs-mds-farmaciaMDS - Farmaciaactive2025-06itinternal
eng.fhir.profile.devR48c2eca08-df6b-4919-a883-c5f08f8ac0b0Valueset Ministero della Salute - ID ASLdraft2023-06
hl7.fhir.it.terminologyR4minsan-idStruttureInterneMinistero della Salute - ID Strutture Interne di Ricoveroactive2025-06itinternal
hl7.fhir.it.terminologyR4minsan-idStruttureMinistero della Salute - ID Strutture Ricoveroactive2025-06itinternal
hl7.fhir.us.codex-radiation-therapyR4codexrt-image-guided-radiotherapy-modality-vsImage Guided Radiotherapy Modality Value Setactivecgp2025-02ussct
ee.hl7.fhir.base.r5R5ee-mode-of-arrivalMode Of Arrivaldraft2023-08eeinternal tho
ee.fhir.terminologyR5mode-of-arrivalMode Of Arrivalactive2025-06eeinternal tho
hl7.terminologyR5v3-ModelMediaTypeModelMediaTypeactive2014-03uvtho
hl7.terminologyR5v3-ConfidentialityModifiersConfidentialityModifiersactive2014-03uvtho
hl7.fhir.uv.molecular-definition-data-typesR6molecular-definition-focus-vsMolecular Definition Focus Value Setinformativecg2025-08uvfhir
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20200901000000MonstermateriaalCodelijstactivenlsct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20200901000000MorfologieCodelijstactivenlsct
hl7.terminologyR5v3-MucosalAbsorptionRouteMucosalAbsorptionRouteactive2014-03uvtho
hl7.terminologyR5v3-MucousMembraneRouteMucousMembraneRouteactive2014-03uvtho
hl7.terminologyR5v3-MultipartMediaTypeMultipartMediaTypeactive2014-03uvtho
hl7.fhir.dk.coreR4dk-core-MunicipalityCodesDK Municipality Codesactive2025-02dkinternal
hl7.fhir.uv.dapR6MyOrgRolesVSCurrent Roles in MyOrginformative0sec2025-07uvfhir
hl7.fhir.be.pssR4MycoplasmaCodesMycoplasma Codesactive2025-07besct
hl7.fhir.cl.recetachileR4VSMetodosMétodos de Administraciónactive2022-01clinternal
us.nlm.vsacR42.16.840.1.113762.1.4.1078.112Chronic kidney disease I10active2023-09usicd
hl7.terminologyR5v3-NativeEntityContiguousNativeEntityContiguousactive2014-03uvtho
hl7.terminologyR5v3-NativeEntityAlaskaNativeEntityAlaskaactive2014-03uvtho
us.nlm.vsacR42.16.840.1.113762.1.4.1260.28Her2 Negativeactive2023-09usncit
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.16--20200901000000TestCodeNHGCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.14.1.8--20200901000000VerrichtingTypeNHGCodelijstactivenl
fhir.org.nz.ig.baseR4nhi-useValid use values for NHIactive2025-06usfhir
fhir.r4.nhsengland.programmeR4England-ObservationCodeEngland Observation Codedraft2024-12ussct
fhir.r4.nhsengland.programmeR4England-ObservationValueCodeEngland Observation Value Codedraft2024-12ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1190.89Maternal Diagnosesactive2023-10usicd
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.14.2.2--20171231000000InterventieNICCodelijstactivenloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.14.2.2--20200901000000InterventieNICCodelijstretirednl
hl7.fhir.be.mycarenetR4eagreementproductorserviceValueSet product or servicetrial-use1fhir2025-06beinternal
hl7.fhir.be.terminologyR4eagreementproductorserviceValueSet product or servicetrial-use1fhir2025-02beinternal
hl7.terminologyR5cited-mediumCited Mediumtrial-use1cds2025-01uvtho
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.4.26.2--20171231000000StatusNaamNOCCodelijstactivenloid
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.4.26.7--20171231000000StatusWaardeNOCCodelijstactivenloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.4.26.7--20200901000000StatusWaardeNOCCodelijstretirednloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.4.26.2--20200901000000StatusNaamNOCCodelijstretirednloid
us.nlm.vsacR42.16.840.1.113762.1.4.1032.55Risk assessments relevant to pain managementactive2024-06usloinc
hl7.fhir.dk.coreR4dk-core-NPUBasicObservationDK Core NPU Basic Observationactive2025-02dkoid
us.nlm.vsacR42.16.840.1.113762.1.4.1108.180Outpatient Prenatal Visitactive2024-09usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1108.182Eclampsiaactive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.184Preexisting Hypertension in Pregnancyactive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.185Postpartum Encounteractive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.186Postpartum Encounteractive2024-10usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1108.187Postpartum Encounteractive2024-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1108.189Spontaneous or Elective Abortionactive2024-10usicd
us.nlm.vsacR42.16.840.1.113762.1.4.1108.190Spontaneous or Elective Abortionactive2024-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1108.191Preeclampsia or Eclampsiaactive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.193Spontaneous or Elective Abortionactive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.179Hypertensive disorders in pregnancyactive2024-10usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1108.192Spontaneous or Elective Abortion Procedureactive2025-01uscms
us.nlm.vsacR42.16.840.1.113762.1.4.1108.183Gestational Hypertensionactive2024-10ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1108.188Preexisting Hypertension in Pregnancyactive2024-10usvsac
hl7.fhir.us.davinci-pctR4PCTGFEItemRevenueVSPCT GFE NUBC Revenue Value Settrial-usefm2025-08us
hl7.fhir.us.davinci-pctR4PCTGFETypeOfBillVSPCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Settrial-usefm2025-08us
signal.core.r4R4provider-taxonomyProvider Taxonomy Codesdraftvocab2023-03usnucc
fhir.cdc.opioid-cds-r4R4oncology-specialty-designationsOncology specialty designations (NUCC)active2023-05usnucc
hl7.fhir.us.vdorR4vdor-gun-owner-codes-vsVDOR Coding Manual Gun Owner Codes Value Setinformativepher2025-06usfhir sct
hl7.fhir.us.registry-protocolsR4NewYorkHeartAssociationAnswersNew York Heart Association OA Answer Listactivecic2023-11usloinc
hl7.org.nz.fhir.ig.formularyR4Bnzf-description-typesNZMT Description typesactive2025-08nz
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.14.1.5--20200901000000VerrichtingTypeNZaCodelijstactivenloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20200901000000NaamgebruikCodelijstactivenltho oid
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20171231000000NaamgebruikCodelijstactivenlfhir oid
hl7.terminologyR5v3-NailRouteNailRouteactive2014-03uvtho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.121Federal Administrative Sexactive2025-02ussct
hl7.terminologyR5v2-0396hl7VS-codingSystemactive2019-12uvtho
hl7.terminologyR5v3-NasalRouteNasalRouteactive2014-03uvtho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.292Non pharmacologic treatments for chronic pain NCIactive2024-06usncit
hl7.terminologyR5v3-EntityClassFoodEntityClassFoodactive2014-03uvtho
hl7.terminologyR5v3-NebulizationNebulizationactive2014-03uvtho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20200901000000TestCodeLOINCCodelijstactivenlloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.581PIM_Avandametactive2023-08usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1032.26Nonopioid pain medicationsactive2023-03usrx
us.nlm.vsacR42.16.840.1.113883.11.20.9.59DIRSectionTypeCodesactive2024-06usvsac
hl7.eu.fhir.idea4rcR4new-cancer-topography-i4rcNew Cancer Topographyactive2025-07eu
hl7.org.nz.fhir.ig.formularyR4Bnzf-document-typeNZF Document Typeactive2025-08nz
hl7.org.nz.fhir.ig.formularyR4Bnzmt-type-codeNzmt typeactive2025-08nz
fhir.org.nz.ig.baseR4coverage-typeCoverage Typeactive2025-06us
fhir.org.nz.ig.baseR4coverage-categoryCoverage Categoryactive2025-06us
fhir.org.nz.ig.baseR4iwiIwiactive2025-06us
ee.fhir.terminologyR5national-identifier-requirementNational identifier requirementactive2025-06eeinternal
hl7.fhir.cl.minsal.eisR4VSNivelAtencionNivelAtencionactive2023-01clinternal
hl7.fhir.cl.minsal.eisR4VSNivelComplejidadNivelComplejidadactive2023-01clinternal
fhir.giisR4NonVaccinationReasonVSNon vaccination reasondraft2025-07usinternal
hl7.fhir.us.hsdsR4NonIndividualSpecialtiesNon-Individual Specialtiestrial-use2hss2023-10usnucc
hl7.fhir.us.directory-queryR4NonIndividualSpecialtiesVSNon-Individual Specialtiesactive2022-12usnucc
hl7.fhir.us.davinci-pdex-plan-netR4NonIndividualSpecialtiesVSNon-Individual Specialtiestrial-usefm2025-02usnucc
hl7.fhir.us.directory-queryR4NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12usfhir tho
hl7.fhir.us.davinci-pdex-plan-netR4NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02usfhir tho
us.nlm.vsacR42.16.840.1.113762.1.4.1046.279Triageactive2025-02ussct
hl7.fhir.us.registry-protocolsR4NonSustainedVentricularTachycardiaTypeNon-Sustained Ventricular Tachycardia Typeactivecic2023-11usfhir
us.nlm.vsacR42.16.840.1.113762.1.4.1213.114NSAIDs Ingredients and Risk of GI Bleedingactive2023-12usrx
openehr.baseR5normal-statusesNormal statusesinformative3fhir2024-04uv
hl7.fhir.us.mcodeR4mcode-normalization-basis-vsNormalization Basis Value Setactivecic2025-02ussct
hl7.eu.fhir.pcspR4vs-naunk-eu-pcspNot Applicable|Unknowndraft2025-08eutho
hl7.eu.fhir.idea4rcR4vs-npunk-eu-i4rcNot Performed|Unknowndraft2025-07eufhir
hl7.eu.fhir.pcspR4vs-npunk-eu-pcspNot Performed|Unknowndraft2025-08eutho
us.nlm.vsacR42.16.840.1.113762.1.4.1247.208Social Determinants of Health Screening Assessments Answersactive2024-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1247.207Social Determinants of Health Screening Assessments Questionsactive2024-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1247.206Social Determinants of Health Screening Assessments And Questionsactive2024-12usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1247.126Social Determinants of Health Screening Assessmentsactive2023-12usloinc
hl7.fhir.us.breast-radiologyR4NotPreviouslySeenVSNotPreviouslySeen ValueSetactive2022-12ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1222.815Drugs of Abuse Screen in Urineactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.898Forearm X Rayactive2024-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.455Metabolic acidosis I10active2023-07usicd
hl7.terminologyR5v2-0309hl7VS-coverageTypeactive2019-12uvtho
us.nlm.vsacR42.16.840.1.113762.1.4.1115.15Upon Death Preferencesactive2025-04usloinc
openehr.baseR5null-flavoursNull Flavoursinformative3fhir2024-08uv
hl7.fhir.us.davinci-crdR4cmslocationcodesCMS Location Codes Value Settrial-use4fm2025-08usfhir
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.20.6.2--20200901000000NummerSoortCodelijstactivenltho
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.20.6.2--20171231000000NummerSoortCodelijstactivenlfhir
hl7.terminologyR5nutrition-intake-categoryNutrition intake category codesdraftoo2020-02uvtho
hl7.fhir.uv.eyecareR4observation-oct-maculaOCT Macula Observable Entities ValueSetactive2019-05uvloinc
hl7.fhir.uv.eyecareR4observation-oct-rnflOCT RNFL Observable Entities ValueSetactive2019-05uvloinc
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.4.26.1--20171231000000StatusNaamOMAHACodelijstactivenloid
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.4.26.5--20171231000000StatusWaardeOMAHACodelijstactivenloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.4.26.1--20200901000000StatusNaamOMAHACodelijstretirednloid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.4.26.5--20200901000000StatusWaardeOMAHACodelijstretirednloid
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1Selected non pharmaceutical therapies for moderate to severe chronic painactive2015-08ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3selected muscle relaxants for pain controlactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3Selected topical agents for pain controlactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2selected non opioids for moderate to severe painactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2Selected opioids for moderate to severe painactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1Selected urine drug screens for opioids indicating testing is completeactive2015-08usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.2Selected urine screening for patients receiving opioid therapyactive2015-08usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.3.1Opioids used for pain controlactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3selected first line medications for pain controlactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1selected follow up visit intervals for opioid monitoringactive2015-08ussct
us.nlm.vsacR42.16.840.1.113883.3.3157.1019Diseases of Urinary Systemactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1301Surgery Integumentary System Breastactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1302Surgery Respiratory System Accessory Sinusesactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1303Surgery Respiratory System Larynxactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1304Surgery Respiratory System Trachea and Bronchiactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1305Surgery Respiratory System Lungs and Pleuraactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.13064Surgery Digestive System Esophagusactive2020-06usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1307Surgery Digestive System Intestines (Except Rectum)active2017-05uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1308Surgery Digestive System Rectumactive2019-08uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1309Surgery Digestive System Anusactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1310Surgery Digestive System Biliary Tractactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1311Surgery Digestive System Abdomen Peritoneum Omentumactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1312Surgery Digestive System Kidneyactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.13133Surgery Digestive System Ureteractive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1314Surgery Digestive System Bladderactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1315Surgery Female Genital System Cervix Uteriactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1316Surgery Female Genital System Corpus Uteriactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1317Surgery Female Genital System Oviduct Ovaryactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1318Surgery Eye and Ocular Adnexa Anterior Segmentactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.13193Other Surgeriesactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.13202SPECT MPIactive2020-06usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.13213Stress Echocardiographyactive2017-05usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.13222Stress MRIactive2020-06usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1323CCTAactive2020-07uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1329Diabetes Mellitusactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1330Renal insufficiencyactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1331Stroke transient ischemic attackactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1332Prior heart failureactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1333Ischemic heart diseaseactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1804Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRIactive2020-08uscpt
us.nlm.vsacR42.16.840.1.113883.3.3157.18143Patients with lumbar spine surgery in the 90 days prior to MRIactive2020-08usvsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1832Canceractive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1838Neoplastic abnormalitiesactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1839Treatment fields for radiation therapyactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1842Postoperative fluid collections and soft tissue changesactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1847Unspecified Immune Deficienciesactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1833Congenital spine and spinal cord malformationsactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1834Inflammatory and autoimmune disordersactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1835Infectious conditionsactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1836Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhageactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1837Spinal cord infarctionactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1840Spinal abnormalities associated with scoliosisactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1841Syringohydromyeliaactive2020-08usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1844IV Drug Abuseactive2022-04usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1845Neurological Impairmentactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1846Human Immunodeficiency Virusactive2020-07usicd
us.nlm.vsacR42.16.840.1.113883.3.3157.1843Traumaactive2020-07usicd
de.basisprofil.r4R4ops-vsOPS ValueSetactive2025-06
hl7.fhir.uv.extensionsR5obligationObligation Codes ValueSettrial-use1fhir2025-08uvfhir
hl7.fhir.cl.minsal.r2boR4r2bo-observaciones-biopsia-VSSet de Valores para Observaciones Biopsiainformativeoo2025-08clsct loinc